Is the publication of China’s first national rare diseases list a new opportunity for global Pharmaceutical Companies?

lynn.huang — Fri, 19 Apr 2019 08:09:17 +0000

In May, 2018, Chinese government published the first rare disease national list, the list contains 121 diseases which published by China National Health Commission in together with other four Chinese government agencies. Although there is not yet a definition of rare disease in China, this first list contains Albinism, Hemophilia, Neonatal Diabetes Mellitus are all disease found with common characteristics of chronic, progressive, diverse symptoms which severely affect patient’s life quality.

Although the number of Chinese first rare diseases list is small comparing with the over 7,000 rare diseases recognized globally, consider the large overall population in China, total patient number that suffered from the listed rare disease cannot be underestimated. Researchers estimate there are at least 16.8 million Chinese with rare diseases.

With the continual publication of the rare diseases catalogue by Chinese government, positive gains will be made with increasing funds and efforts in the field of clinical and science research, also it is predicable that more overseas clinical-valued drugs, effective and affordable treatments will be available for patients with rare diseases.

Please click the link at the end to download the whole list .

First National Rare Diseases List in China

rare disease list – Accestra Consulting

Is the publication of China’s first national rare diseases list a new opportunity for global Pharmaceutical Companies?